Back

Associations of Prenatal Cannabis Exposure and Neonatal Brain Development in the HBCD Cohort

Shah, L.; Planalp, E.; McDonald, R.; Regner, C.; Atluru, S.; Alexander, A.; Ossorio, P.; Poehlmann, J.; Dean, D.

2026-03-03 pediatrics
10.64898/2026.03.02.26347436 medRxiv
Show abstract

ImportancePrenatal cannabis exposure is increasing in prevalence, yet its associations with early brain development--particularly how the timing and frequency of exposure across gestation relate to neonatal brain structure--remain insufficiently understood. Clarifying these associations is essential for informing early risk identification and guiding perinatal care. ObjectiveTo examine associations between patterns of maternal prenatal cannabis exposure, including exposure presence, gestational timing, and frequency of exposure, and neonatal brain structure and microstructure during the first month of life. Design, Setting, and ParticipantsThis cohort study included 1,782 mother-infant dyads (221 with PCE) from the HEALthy Brain and Child Development Study. Mother-reported prenatal cannabis exposure was assessed using the validated Timeline Follow-back method. Infants underwent natural-sleep magnetic resonance imaging, including T2-weighted structural imaging and diffusion imaging, within the first month of life. Main Outcomes and MeasuresAssociations between prenatal cannabis exposure and regional T2-weighted volumes and diffusion white matter microstructure metrics examined (1) exposure presence, (2) gestational timing of exposure, and (3) frequency of exposure within exposed infants. ResultsAny prenatal cannabis exposure was associated with brain volume differences in cerebellar and subcortical limbic regions, including smaller amygdala, thalamic, and cerebellar vermis volumes and larger caudate, hippocampal, and cerebellar cortex volumes. Timing-specific analyses revealed divergent patterns: first trimester exposure was associated with smaller volumes in select regions, whereas exposure that continued into the third trimester was associated with larger volumes in overlapping structures, with additional subcortical volumetric differences observed. White matter microstructure alterations were observed only among infants with exposure that continued into the third trimester. Within the exposed subgroup, higher frequency of cannabis exposure was associated with larger cerebral white matter volumes and white matter microstructural differences in white matter regions. Conclusions and RelevanceIn infants with maternal prenatal cannabis exposure, we observed timing- and frequency-dependent differences in brain development within the first month of life. These findings underscore the importance of considering not only the presence of exposure, but also when and how much cannabis is used during pregnancy to support targeted prenatal counseling and early developmental monitoring for exposed infants. Key PointsO_ST_ABSQuestionC_ST_ABSIs prenatal cannabis exposure associated with brain development in the first month of life? FindingsIn a cohort[ABS] of 1,782 mother-infant dyads, prenatal cannabis exposure was associated with region-specific differences in neonatal brain volumes. Brain volume and diffusion white matter microstructure associations differed between exposure limited to the first trimester versus exposure that continued into the third trimester. Greater frequency of exposure across gestation was also associated with volumetric and microstructural differences. MeaningThe timing and frequency of prenatal cannabis exposure is associated with alterations in neonatal brain development, underscoring the importance of addressing cannabis use in pregnancy.

Matching journals

The top 5 journals account for 50% of the predicted probability mass.

1
NeuroImage: Clinical
132 papers in training set
Top 0.1%
23.0%
2
JAMA Network Open
127 papers in training set
Top 0.1%
10.6%
3
Developmental Cognitive Neuroscience
81 papers in training set
Top 0.1%
7.3%
4
Journal of Child Psychology and Psychiatry
25 papers in training set
Top 0.1%
6.5%
5
Psychological Medicine
74 papers in training set
Top 0.3%
4.9%
50% of probability mass above
6
Neuroscience & Biobehavioral Reviews
43 papers in training set
Top 0.1%
4.4%
7
Biology of Sex Differences
29 papers in training set
Top 0.1%
4.4%
8
Addiction
25 papers in training set
Top 0.2%
3.7%
9
Translational Psychiatry
219 papers in training set
Top 2%
3.1%
10
Brain, Behavior, and Immunity
105 papers in training set
Top 1%
1.7%
11
Cerebral Cortex
357 papers in training set
Top 1%
1.5%
12
BMC Medicine
163 papers in training set
Top 4%
1.4%
13
Journal of Affective Disorders
81 papers in training set
Top 1%
1.4%
14
BMJ Open
554 papers in training set
Top 10%
1.4%
15
Scientific Reports
3102 papers in training set
Top 63%
1.4%
16
Biological Psychiatry: Cognitive Neuroscience and Neuroimaging
62 papers in training set
Top 1%
1.2%
17
PLOS ONE
4510 papers in training set
Top 60%
1.2%
18
Neuroimage: Reports
22 papers in training set
Top 0.1%
1.2%
19
Drug and Alcohol Dependence
37 papers in training set
Top 0.5%
1.0%
20
The Journal of Pediatrics
15 papers in training set
Top 0.5%
0.9%
21
Human Reproduction
18 papers in training set
Top 0.4%
0.8%
22
Spatial and Spatio-temporal Epidemiology
10 papers in training set
Top 0.2%
0.8%
23
The British Journal of Psychiatry
21 papers in training set
Top 0.9%
0.8%
24
Human Brain Mapping
295 papers in training set
Top 4%
0.7%
25
Behavioural Brain Research
70 papers in training set
Top 1%
0.7%
26
Frontiers in Human Neuroscience
67 papers in training set
Top 3%
0.7%
27
Nutrients
64 papers in training set
Top 2%
0.7%
28
eLife
5422 papers in training set
Top 61%
0.7%
29
Nature Mental Health
18 papers in training set
Top 0.4%
0.7%
30
JAMA Psychiatry
13 papers in training set
Top 0.7%
0.7%